Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2003 09:00 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies Receives 90-Day Extension from NASDAQ

RENO, Nev., June 5, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received a letter from the NASDAQ Stock Market noting that the company meets the initial...
June 03, 2003 09:00 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies Receives Positive RenaZorb Animal Test Results; RenaZorb, A Nanotechnology-Based Drug Candidate For Phosphate Control in Kidney Dialysis Patients, Shows Phosphate Binding In Dogs And 5/6 Nephrectomized Rats

RENO, Nev., June 3, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has negotiated an agreement allowing the disclosure of new animal testing data to...
May 28, 2003 10:00 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies Completes $1.3 Million Private Placement; Company Expects 90-Day Extension on NASDAQ SmallCap Market

RENO, Nev., May 28, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has completed a $1.3 million private placement. Under the terms of the governing...
May 20, 2003 10:00 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies Targets Government Grant Programs For Development Revenue

RENO, Nev., May 20, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) said today that the company is aggressively seeking revenues from government grant programs to support several of...
May 13, 2003 14:32 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies President Interviewed by Chemical Market Reporter; Altair Pigment Process Continues to Generate International and Domestic Interest

RENO, Nev., May 13, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that an interview with the company's Present, Dr. Rudi E. Moerck, has been published in the April...
May 09, 2003 10:31 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies Reports Passage of Science Committee Legislation by U.S. House of Representatives

RENO, Nev., May 9, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) reported today that the U. S. House of Representatives passed the Science Committee legislation which authorizes a...
April 29, 2003 11:48 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies' President Provides Shareholder Update; Altair Receives Patent Number For Third Patent Pertaining To Its Hydrochloride Pigment Process

RENO, Nev., April 29, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received the patent number for its third in a series of patents pertaining to Altair's...
April 17, 2003 09:41 ET | Source: Altair Nanotechnologies Inc.

Nevada Senator Harry Reid Tours Altair Nanotechnologies' Corporate Headquarters and Manufacturing Facility

RENO, Nev., April 17, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that Nevada Senator Harry Reid met with Altair management and representatives from Western...
April 11, 2003 10:30 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies, Inc. Retains RBC Capital Markets as its Financial Advisor

RENO, Nev., April 11, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has retained RBC Capital Markets as its exclusive financial advisor to assist the company...
April 11, 2003 09:00 ET | Source: Altair Nanotechnologies Inc.

Altair Nanotechnologies, Inc. Reports Positive Results from In Vivo Testing of RenaZorb

RENO, Nev., April 11, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) reported today that data from laboratory testing and animal testing of RenaZorb(tm), the company's new drug...